-
Full year 2021 revenue of
$887 million grew 39% year-over-year; 5-year CAGR 26% - Full year 2021 inspection & metrology revenue grew 130% year-over-year
- Full year 2021 interface products revenue grew 25% year-over-year
- Q4 Gross margin of 44.0%; non-GAAP gross margin of 44.1%
- Q4 design-wins expanding Semitest sales in automotive, display driver and RF-FEM segments
- Repurchased 206,572 shares of Common Stock in Q4
The Company also reported non-GAAP results, with fourth quarter 2021 income of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Results (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
(in millions, except per share amounts) |
Q4 FY
|
|
Q3 FY
|
|
Q4 FY
|
|
12
|
|
12
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Net sales |
|
$ |
191.9 |
|
$ |
225.1 |
|
$ |
202.4 |
|
$ |
887.2 |
|
$ |
636.0 |
|
|
|
|
|
Income (loss) |
|
$ |
20.9 |
|
$ |
23.7 |
|
$ |
14.9 |
|
$ |
167.3 |
|
$ |
(13.8 |
) |
|
|
|
|
Income (loss) per share |
|
$ |
0.42 |
|
$ |
0.48 |
|
$ |
0.34 |
|
$ |
3.45 |
|
$ |
(0.33 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Results (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
(in millions, except per share amounts) |
Q4 FY
|
|
Q3 FY
|
|
Q4 FY
|
|
12
|
|
12
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Income |
|
$ |
35.6 |
|
$ |
34.6 |
|
$ |
31.8 |
|
$ |
155.1 |
|
$ |
50.7 |
|
|
|
|
|
Income per share |
|
$ |
0.72 |
|
$ |
0.70 |
|
$ |
0.73 |
|
$ |
3.20 |
|
$ |
1.19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
All amounts presented are from continuing operations. |
Total cash and investments at year-end 2021 were
“Cohu delivered record revenue and profitability in 2021 with non-GAAP EPS of
Conference Call Information:
The Company will host a live conference call and webcast with slides to discuss fourth quarter 2021 results at
About
Use of Non-GAAP Financial Information:
Included within this press release and accompanying materials are non-GAAP financial measures, including non-GAAP Gross Margin/Profit, Income and Income (adjusted earnings) per share, Operating Income, Operating Expense, effective tax rate and Adjusted EBITDA that supplement the Company’s Condensed Consolidated Statements of Operations prepared under generally accepted accounting principles (GAAP). These non-GAAP financial measures adjust the Company’s actual results prepared under GAAP to exclude charges and the related income tax effect for: share-based compensation, the amortization of purchased intangible assets, restructuring costs, manufacturing transition and severance costs, asset impairment charges, gain on sale of business, gain on sale of facility, employer payroll taxes related to accelerated vesting share-based awards, depreciation of purchase accounting adjustments to property, plant and equipment, reduction of indemnification receivable, amortization of cloud-based software implementation costs (Adjusted EBITDA only) and gain (loss) on extinguishment of debt (Adjusted EBITDA only). Reconciliations of GAAP to non-GAAP amounts for the periods presented herein are provided in schedules accompanying this release and should be considered together with the Condensed Consolidated Statements of Operations. With respect to any forward looking non-GAAP figures, we are unable to provide without unreasonable efforts, at this time, a GAAP to non-GAAP reconciliation of any forward-looking figures due to their inherent uncertainty.
These non-GAAP measures are not meant as a substitute for GAAP, but are included solely for informational and comparative purposes. The Company’s management believes that this information can assist investors in evaluating the Company’s operational trends, financial performance, and cash generating capacity. Management uses non-GAAP measures for a variety of reasons, including to make operational decisions, to determine executive compensation in part, to forecast future operational results, and for comparison to our annual operating plan. However, the non-GAAP financial measures should not be regarded as a replacement for (or superior to) corresponding, similarly captioned, GAAP measures.
Forward Looking Statements:
Certain statements contained in this release and accompanying materials may be considered forward-looking statements within the meaning of the
Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the ongoing global COVID-19 pandemic has adversely affected, and is continuing to adversely affect, our business, financial condition and results of operations; the COVID-19 pandemic has impacted, and is expected to continue to negatively impact, the operations of our key suppliers, customers and other business partners; we are making investments in new products and product enhancements, which may adversely affect our operating results and these investments may not be commercially successful; we have manufacturing operations in
These and other risks and uncertainties are discussed more fully in Cohu’s filings with the
For press releases and other information of interest to investors, please visit Cohu’s website at www.cohu.com.
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(Unaudited) |
||||||||||||||||
(in thousands, except per share amounts) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Three Months Ended (1) |
Twelve Months Ended (1) |
||||||||||||||
|
|
|
|
|
||||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net sales |
$ |
191,860 |
|
$ |
202,355 |
|
$ |
887,214 |
|
$ |
636,007 |
|
||||
Cost and expenses: |
|
|
|
|
|
|
|
|
||||||||
Cost of sales (excluding amortization) |
|
107,466 |
|
|
111,114 |
|
|
500,253 |
|
|
364,225 |
|
||||
Research and development |
|
22,596 |
|
|
22,762 |
|
|
91,963 |
|
|
86,151 |
|
||||
Selling, general and administrative |
|
31,123 |
|
|
33,584 |
|
|
126,958 |
|
|
129,248 |
|
||||
Amortization of purchased intangible assets |
|
8,246 |
|
|
9,898 |
|
|
35,414 |
|
|
38,746 |
|
||||
(Gain) loss on sale of PCB Test business (2) |
|
4,939 |
|
|
- |
|
|
(70,815 |
) |
|
- |
|
||||
Restructuring charges |
|
(165 |
) |
|
6,223 |
|
|
1,823 |
|
|
7,623 |
|
||||
Impairment charges (3) |
|
100 |
|
|
- |
|
|
100 |
|
|
11,249 |
|
||||
Gain on sale of facilities (4) |
|
- |
|
|
- |
|
|
- |
|
|
(4,495 |
) |
||||
|
|
174,305 |
|
|
183,581 |
|
|
685,696 |
|
|
632,747 |
|
||||
Income from operations |
|
17,555 |
|
|
18,774 |
|
|
201,518 |
|
|
3,260 |
|
||||
Other (expense) income: |
|
|
|
|
|
|
|
|
||||||||
Interest expense |
|
(1,041 |
) |
|
(2,855 |
) |
|
(6,413 |
) |
|
(13,759 |
) |
||||
Interest income |
|
42 |
|
|
14 |
|
|
239 |
|
|
224 |
|
||||
Foreign transaction gain (loss) |
|
726 |
|
|
(642 |
) |
|
411 |
|
|
(3,170 |
) |
||||
Gain (loss) on extinguishment of debt (5) |
|
- |
|
|
(25 |
) |
|
(3,411 |
) |
|
268 |
|
||||
Income (loss) from continuing operations before taxes |
|
17,282 |
|
|
15,266 |
|
|
192,344 |
|
|
(13,177 |
) |
||||
Income tax provision (benefit) |
|
(3,607 |
) |
|
405 |
|
|
25,019 |
|
|
666 |
|
||||
Income (loss) from continuing operations |
|
20,889 |
|
|
14,861 |
|
|
167,325 |
|
|
(13,843 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Discontinued operations: (6) |
|
|
|
|
|
|
|
|
||||||||
Income from discontinued operations before taxes |
|
- |
|
|
- |
|
|
- |
|
|
46 |
|
||||
Income tax provision |
|
- |
|
|
- |
|
|
- |
|
|
4 |
|
||||
Income from discontinued operations |
|
- |
|
|
- |
|
|
- |
|
|
42 |
|
||||
Net income (loss) |
$ |
20,889 |
|
$ |
14,861 |
|
$ |
167,325 |
|
$ |
(13,801 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Income (loss) from continuing operations |
$ |
0.43 |
|
$ |
0.35 |
|
$ |
3.53 |
|
$ |
(0.33 |
) |
||||
Income from discontinued operations |
|
- |
|
|
- |
|
|
- |
|
|
0.00 |
|
||||
Net income (loss) |
$ |
0.43 |
|
$ |
0.35 |
|
$ |
3.53 |
|
$ |
(0.33 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Income (loss) from continuing operations |
$ |
0.42 |
|
$ |
0.34 |
|
$ |
3.45 |
|
$ |
(0.33 |
) |
||||
Income from discontinued operations |
|
- |
|
|
- |
|
|
- |
|
|
0.00 |
|
||||
Net income (loss) |
$ |
0.42 |
|
$ |
0.34 |
|
$ |
3.45 |
|
$ |
(0.33 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used in computing income (loss) per share: (7) |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
48,657 |
|
|
42,125 |
|
|
47,409 |
|
|
41,854 |
|
||||
Diluted |
|
49,427 |
|
|
43,486 |
|
|
48,460 |
|
|
41,854 |
|
||||
|
|
|
|
|
|
|
|
|
(1) |
The three- and twelve-month periods ended |
|
(2) |
On |
|
(3) |
Included in our results for the three- and twelve-month periods ended |
|
(4) |
During 2020 we completed the sale of our facilities in Rosenheim, |
|
(5) |
Early prepayments of outstanding Term Loan B made during 2021 resulted in a loss from the extinguishment of debt. In the fourth quarter of 2020 we repurchased and retired |
|
(6) |
On |
|
(7) |
For the twelve-month period ended |
|
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(Unaudited) |
||||||
(in thousands) |
||||||
|
|
|
||||
|
2021 |
2020 |
||||
Assets: |
|
|
|
|
||
Current assets: |
|
|
|
|
||
Cash and investments |
$ |
379,905 |
$ |
170,027 |
||
Accounts receivable |
|
192,873 |
|
151,919 |
||
Inventories |
|
161,053 |
|
142,500 |
||
Other current assets |
|
16,962 |
|
20,600 |
||
Total current assets |
|
750,793 |
|
485,046 |
||
Property, plant & equipment, net |
|
63,957 |
|
66,916 |
||
|
|
219,791 |
|
252,304 |
||
Intangible assets, net |
|
177,320 |
|
233,685 |
||
Operating lease right of use assets |
|
25,060 |
|
29,203 |
||
Other assets |
|
22,123 |
|
23,192 |
||
Total assets |
$ |
1,259,044 |
$ |
1,090,346 |
||
|
|
|
|
|
||
Liabilities & Stockholders’ Equity: |
|
|
|
|
||
Current liabilities: |
|
|
|
|
||
Short-term borrowings |
$ |
3,059 |
$ |
5,314 |
||
Current installments of long-term debt (1) |
|
11,338 |
|
3,075 |
||
Deferred profit |
|
13,208 |
|
8,671 |
||
Other current liabilities |
|
164,854 |
|
157,393 |
||
Total current liabilities |
|
192,459 |
|
174,453 |
||
Long-term debt |
|
103,393 |
|
311,551 |
||
Non-current operating lease liabilities |
|
22,040 |
|
25,787 |
||
Other noncurrent liabilities |
|
58,650 |
|
66,267 |
||
|
|
882,502 |
|
512,288 |
||
Total liabilities & stockholders’ equity |
$ |
1,259,044 |
$ |
1,090,346 |
||
|
|
|
|
|
(1) |
On |
|
||||||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||||||
(in thousands, except per share amounts) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|||||||||
|
2021 |
2021 |
2020 |
|||||||||
Income from operations - GAAP basis (a) |
$ |
17,555 |
|
$ |
33,716 |
|
$ |
18,774 |
|
|||
Non-GAAP adjustments: |
|
|
|
|
|
|
||||||
Share-based compensation included in (b): |
|
|
|
|
|
|
||||||
Cost of sales (COS) |
|
136 |
|
|
239 |
|
|
252 |
|
|||
Research and development (R&D) |
|
584 |
|
|
889 |
|
|
802 |
|
|||
Selling, general and administrative (SG&A) |
|
2,329 |
|
|
2,586 |
|
|
2,867 |
|
|||
|
|
3,049 |
|
|
3,714 |
|
|
3,921 |
|
|||
Amortization of purchased intangible assets (c) |
|
8,246 |
|
|
8,879 |
|
|
9,898 |
|
|||
Restructuring charges related to inventory adjustments in COS (d) |
|
141 |
|
|
(836 |
) |
|
(550 |
) |
|||
Restructuring charges included in operating expenses (d): |
|
|
|
|
|
|
||||||
Selling, general and administrative |
|
10 |
|
|
- |
|
|
- |
|
|||
Restructuring charges (d) |
|
(165 |
) |
|
31 |
|
|
6,223 |
|
|||
Manufacturing and sales transition costs included in (e): |
|
|
|
|
|
|
||||||
COS |
|
(7 |
) |
|
- |
|
|
26 |
|
|||
R&D |
|
- |
|
|
- |
|
|
6 |
|
|||
SG&A |
|
(2 |
) |
|
- |
|
|
458 |
|
|||
|
|
(9 |
) |
|
- |
|
|
490 |
|
|||
Impairment charges (f) |
|
100 |
|
|
- |
|
|
- |
|
|||
Loss (gain) on sale of PCB Test business (g) |
|
4,939 |
|
|
(90 |
) |
|
- |
|
|||
PP&E step-up included in SG&A (h) |
|
- |
|
|
145 |
|
|
145 |
|
|||
Reduction of indemnification receivable included in SG&A (i) |
|
75 |
|
|
- |
|
|
111 |
|
|||
Payroll taxes related to accelerated vesting of share-based awards included in SG&A (j) |
|
- |
|
|
- |
|
|
263 |
|
|||
Income from operations - non-GAAP basis (k) |
$ |
33,941 |
|
$ |
45,559 |
|
$ |
39,275 |
|
|||
|
|
|
|
|
|
|
||||||
Income from continuing operations - GAAP basis |
$ |
20,889 |
|
$ |
23,733 |
|
$ |
14,861 |
|
|||
Non-GAAP adjustments (as scheduled above) |
|
16,386 |
|
|
11,843 |
|
|
20,501 |
|
|||
Tax effect of non-GAAP adjustments (l) |
|
(1,650 |
) |
|
(964 |
) |
|
(3,556 |
) |
|||
Income from continuing operations - non-GAAP basis |
$ |
35,625 |
|
$ |
34,612 |
|
$ |
31,806 |
|
|||
|
|
|
|
|
|
|
||||||
GAAP income from continuing operations per share - diluted |
$ |
0.42 |
|
$ |
0.48 |
|
$ |
0.34 |
|
|||
|
|
|
|
|
|
|
||||||
Non-GAAP income from continuing operations per share - diluted (m) |
$ |
0.72 |
|
$ |
0.70 |
|
$ |
0.73 |
|
|||
|
|
|
|
|
|
|
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company's operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with
(a) |
9.1%, 15.0% and 9.3% of net sales, respectively. |
|
(b) |
To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan. |
|
(c) |
To eliminate the amortization of acquired intangible assets. |
|
(d) |
To eliminate restructuring costs incurred related to the integration of |
|
(e) |
To eliminate manufacturing and sales transition and severance costs. |
|
(f) |
To eliminate impairment charges recorded to adjust IPR&D assets obtained in the acquisition of |
|
(g) |
To eliminate the gains generated from the sale of the PCB Test business. |
|
(h) |
To eliminate the accelerated depreciation from the property, plant & equipment step-up related to the acquisition of |
|
(i) |
To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable. |
|
(j) |
To eliminate the impact of employer payroll taxes associated with the acceleration of |
|
(k) |
17.7%, 20.2% and 19.4% of net sales, respectively. |
|
(l) |
To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates. |
|
(m) |
All periods presented were computed using the number of GAAP diluted shares outstanding. |
|
||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||
(in thousands, except per share amounts) |
||||||||
|
Twelve Months Ended |
|||||||
|
|
|
||||||
|
2021 |
2020 |
||||||
Income from operations - GAAP basis (a) |
$ |
201,518 |
|
$ |
3,260 |
|
||
Non-GAAP adjustments: |
|
|
|
|
||||
Share-based compensation included in (b): |
|
|
|
|
||||
Cost of sales (COS) |
|
828 |
|
|
893 |
|
||
Research and development (R&D) |
|
3,017 |
|
|
3,245 |
|
||
Selling, general and administrative (SG&A) |
|
9,947 |
|
|
10,096 |
|
||
|
|
13,792 |
|
|
14,234 |
|
||
Amortization of purchased intangible assets (c) |
|
35,414 |
|
|
38,746 |
|
||
Restructuring charges related to inventory adjustments in COS (d) |
|
(558 |
) |
|
3,731 |
|
||
Restructuring charges included in operating expenses (d): |
|
|
|
|
||||
Selling, general and administrative |
|
10 |
|
|
- |
|
||
Restructuring charges (d) |
|
1,823 |
|
|
7,623 |
|
||
Manufacturing and sales transition costs included in (e): |
|
|
|
|
||||
COS |
|
(7 |
) |
|
26 |
|
||
R&D |
|
- |
|
|
6 |
|
||
SG&A |
|
(2 |
) |
|
776 |
|
||
|
|
(9 |
) |
|
808 |
|
||
Impairment charges (f) |
|
100 |
|
|
11,249 |
|
||
|
|
|
|
|
||||
Gain on sale of PCB Test business (g) |
|
(70,815 |
) |
|
- |
|
||
Gain on sale of facility (g) |
|
- |
|
|
(4,495 |
) |
||
PP&E step-up included in SG&A (h) |
|
435 |
|
|
874 |
|
||
Reduction of indemnification receivable included in SG&A (i) |
|
75 |
|
|
111 |
|
||
Payroll taxes related to accelerated vesting of share-based awards included in SG&A (j) |
|
300 |
|
|
263 |
|
||
|
|
|
|
|
||||
Income from operations - non-GAAP basis (k) |
$ |
182,085 |
|
$ |
76,404 |
|
||
|
|
|
|
|
||||
Income (loss) from continuing operations - GAAP basis |
$ |
167,325 |
|
$ |
(13,843 |
) |
||
Non-GAAP adjustments (as scheduled above) |
|
(19,433 |
) |
|
73,144 |
|
||
Tax effect of non-GAAP adjustments (l) |
|
7,194 |
|
|
(8,607 |
) |
||
Income from continuing operations - non-GAAP basis |
$ |
155,086 |
|
$ |
50,694 |
|
||
|
|
|
|
|
||||
GAAP income (loss) per share from continuing operations - diluted |
$ |
3.45 |
|
$ |
(0.33 |
) |
||
|
|
|
|
|
||||
Non-GAAP income per share - diluted (m) |
$ |
3.20 |
|
$ |
1.19 |
|
||
|
|
|
|
|
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company's operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with
(a) |
22.7% and 0.5% of net sales, respectively. |
|
(b) |
To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan. |
|
(c) |
To eliminate the amortization of acquired intangible assets. |
|
(d) |
To eliminate restructuring costs incurred related to the integration of |
|
(e) |
To eliminate manufacturing and sales transition and severance costs. |
|
(f) |
To eliminate impairment charges recorded to adjust IPR&D assets obtained in the acquisition of |
|
(g) |
To eliminate the gains generated from the sale of the PCB Test business and the facilities in Rosenheim, |
|
(h) |
To eliminate the property, plant & equipment step-up depreciation accelerated related to the acquisition of |
|
(i) |
To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable. |
|
(j) |
To eliminate the impact of employer payroll taxes associated with the acceleration of |
|
(k) |
20.5% and 12.0% of net sales, respectively. |
|
(l) |
To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates. |
|
(m) |
The twelve months ended |
|
||||||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||||||
(in thousands) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|||||||||
|
2021 |
2021 |
2020 |
|||||||||
|
|
|
|
|
|
|
||||||
Gross Profit Reconciliation |
|
|
|
|
|
|
||||||
Gross profit - GAAP basis (excluding amortization) (1) |
$ |
84,394 |
|
$ |
95,705 |
|
$ |
91,241 |
|
|||
Non-GAAP adjustments to cost of sales (as scheduled above) |
|
270 |
|
|
(597 |
) |
|
(272 |
) |
|||
Gross profit - Non-GAAP basis |
$ |
84,664 |
|
$ |
95,108 |
|
$ |
90,969 |
|
|||
|
|
|
|
|
|
|
||||||
As a percentage of net sales: |
|
|
|
|
|
|
||||||
GAAP gross profit |
|
44.0 |
% |
|
42.5 |
% |
|
45.1 |
% |
|||
Non-GAAP gross profit |
|
44.1 |
% |
|
42.3 |
% |
|
45.0 |
% |
|||
|
|
|
|
|
|
|
||||||
Adjusted EBITDA Reconciliation |
|
|
|
|
|
|
||||||
Net income - GAAP Basis |
$ |
20,889 |
|
$ |
23,733 |
|
$ |
14,861 |
|
|||
Income tax provision (benefit) |
|
(3,607 |
) |
|
7,392 |
|
|
405 |
|
|||
Interest expense |
|
1,041 |
|
|
966 |
|
|
2,855 |
|
|||
Interest income |
|
(42 |
) |
|
(53 |
) |
|
(14 |
) |
|||
Amortization of purchased intangible assets |
|
8,246 |
|
|
8,879 |
|
|
9,898 |
|
|||
Depreciation |
|
3,219 |
|
|
3,226 |
|
|
3,565 |
|
|||
Amortization of cloud-based software implementation costs (2) |
|
487 |
|
|
409 |
|
|
360 |
|
|||
Loss on extinguishment of debt |
|
- |
|
|
1,650 |
|
|
25 |
|
|||
Other non-GAAP adjustments (as scheduled above) |
|
8,140 |
|
|
2,819 |
|
|
10,458 |
|
|||
Adjusted EBITDA |
$ |
38,373 |
|
$ |
49,021 |
|
$ |
42,413 |
|
|||
|
|
|
|
|
|
|
||||||
As a percentage of net sales: |
|
|
|
|
|
|
||||||
Net income - GAAP Basis |
|
10.9 |
% |
|
10.5 |
% |
|
7.3 |
% |
|||
Adjusted EBITDA |
|
20.0 |
% |
|
21.8 |
% |
|
21.0 |
% |
|||
|
|
|
|
|
|
|
||||||
Operating Expense Reconciliation |
|
|
|
|
|
|
||||||
Operating Expense - GAAP basis |
$ |
61,900 |
|
$ |
62,079 |
|
$ |
72,467 |
|
|||
Non-GAAP adjustments to operating expenses (as scheduled above) |
|
(11,177 |
) |
|
(12,530 |
) |
|
(20,773 |
) |
|||
Operating Expenses - Non-GAAP basis |
$ |
50,723 |
|
$ |
49,549 |
|
$ |
51,694 |
|
|||
|
|
|
|
|
|
|
(1) |
Excludes amortization of |
|
(2) |
Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A. |
|
Twelve Months Ended |
|||||||
|
|
|
||||||
|
2021 |
2020 |
||||||
Gross Profit Reconciliation |
|
|
|
|
||||
Gross profit - GAAP basis (excluding amortization) (1) |
$ |
386,961 |
|
$ |
271,782 |
|
||
Non-GAAP adjustments to cost of sales (as scheduled above) |
|
263 |
|
|
4,650 |
|
||
Gross profit - Non-GAAP basis |
$ |
387,224 |
|
$ |
276,432 |
|
||
|
|
|
|
|
||||
As a percentage of net sales: |
|
|
|
|
||||
GAAP gross profit |
|
43.6 |
% |
|
42.7 |
% |
||
Non-GAAP gross profit |
|
43.6 |
% |
|
43.5 |
% |
||
|
|
|
|
|
||||
Adjusted EBITDA Reconciliation |
|
|
|
|
||||
Net income (loss) - GAAP Basis |
$ |
167,325 |
|
$ |
(13,801 |
) |
||
Income from discontinued operations |
|
- |
|
|
(42 |
) |
||
Income tax provision |
|
25,019 |
|
|
666 |
|
||
Interest expense |
|
6,413 |
|
|
13,759 |
|
||
Interest income |
|
(239 |
) |
|
(224 |
) |
||
Amortization of purchased intangible assets |
|
35,414 |
|
|
38,746 |
|
||
Depreciation |
|
13,153 |
|
|
14,000 |
|
||
Amortization of cloud-based software implementation costs (2) |
|
1,644 |
|
|
1,191 |
|
||
(Gain) loss on extinguishment of debt |
|
3,411 |
|
|
(268 |
) |
||
Other non-GAAP adjustments (as scheduled above) |
|
(55,282 |
) |
|
33,524 |
|
||
Adjusted EBITDA |
$ |
196,858 |
|
$ |
87,551 |
|
||
|
|
|
|
|
||||
As a percentage of net sales: |
|
|
|
|
||||
Net income (loss) - GAAP Basis |
|
18.9 |
% |
|
(2.2 |
)% |
||
Adjusted EBITDA |
|
22.2 |
% |
|
13.8 |
% |
||
|
|
|
|
|
||||
Operating Expense Reconciliation |
|
|
|
|
||||
Operating Expense - GAAP basis |
$ |
256,258 |
|
$ |
268,522 |
|
||
Non-GAAP adjustments to operating expenses (as scheduled above) |
|
(51,119 |
) |
|
(68,494 |
) |
||
Operating Expenses - Non-GAAP basis |
$ |
205,139 |
|
$ |
200,028 |
|
||
|
|
|
|
|
(1) |
Excludes amortization of |
|
(2) |
Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005789/en/
858-848-8106
Source: